0001209191-19-031524.txt : 20190520
0001209191-19-031524.hdr.sgml : 20190520
20190520182754
ACCESSION NUMBER: 0001209191-19-031524
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190516
FILED AS OF DATE: 20190520
DATE AS OF CHANGE: 20190520
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bright Rex
CENTRAL INDEX KEY: 0001327501
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36621
FILM NUMBER: 19840346
MAIL ADDRESS:
STREET 1: 5641 LAKE VISTA DRIVE
CITY: BONSALL
STATE: CA
ZIP: 92003
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Foamix Pharmaceuticals Ltd.
CENTRAL INDEX KEY: 0001606645
STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
IRS NUMBER: 000000000
STATE OF INCORPORATION: L3
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2 HOLZMAN ST.
STREET 2: WEIZMANN SCIENCE PARK
CITY: REHOVOT
STATE: L3
ZIP: 76704
BUSINESS PHONE: 97289316233
MAIL ADDRESS:
STREET 1: 2 HOLZMAN ST.
STREET 2: WEIZMANN SCIENCE PARK
CITY: REHOVOT
STATE: L3
ZIP: 76704
FORMER COMPANY:
FORMER CONFORMED NAME: Foamix Ltd.
DATE OF NAME CHANGE: 20140428
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-05-16
0
0001606645
Foamix Pharmaceuticals Ltd.
FOMX
0001327501
Bright Rex
C/O FOAMIX PHARMACEUTICALS LTD.
2 HOLTZMAN STREET
REHOVOT
L3
7670402
ISRAEL
1
0
0
0
Options
2.66
2019-05-16
4
A
0
49412
0.00
A
2029-05-16
Ordinary Shares
49412
49412
D
Each option represents a contingent right to purchase one ordinary share of the issuer.
The ordinary shares underlying these options vest over a 12 month period, in equal, quarterly installments, ending May 16, 2020.
/s/ Mutya Harsch as attorney-in-fact for Rex Bright
2019-05-20